Latest news with #NeurotechReports
Associated Press
31-03-2025
- Business
- Associated Press
Pain Neuromodulation Market to Reach $6.5 Billion by 2030
- The market includes spinal cord stimulation (SCS) systems as well as peripheral nerve stimulation (PNS) systems - SAN FRANCISCO, Calif., March 31, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the newsletter Neurotech Business Report, announced the availability of a new market research report that forecasts the growth of the worldwide market for implanted pain neuromodulation systems. According to the newly published report, ' The Market for Implanted Pain Neuromodulation Systems: 2025-2030,' the worldwide market will be $3.37 billion in 2025, growing to $6.49 billion by 2030, which represents a 12% compound annual growth rate. The market includes spinal cord stimulation (SCS) systems as well as peripheral nerve stimulation (PNS) systems. Neurotech Reports estimates that the PNS market will grow at a 29% CAGR between 2025 and 2030. Major players in the SCS market include Medtronic, Abbott, Boston Scientific, and Nevro, which was recently acquired by medtech manufacturer Globus Medical. The report includes Neurotech Reports editors' analysis of the impact of this transaction on the competitive landscape of the SCS market. Newer players in the SCS market include Saluda Medical, which pioneered the concept of closed-loop SCS, and European firm Biotronik. Leading competitors in the PNS space include Curonix, which markets an injectable pain stimulator, SPR, which markets a percutaneous system, Nalu Medical, Bioventus, and Mainstay Medical, which markets a restorative neuromodulation system for treatment of back pain of mechanical origin. Several startup and emerging firms are poised to enter the space in coming years. The Market for Implanted Pain Neuromodulation Systems: 2025-2030 was authored by the editors of Neurotech Reports, including James Cavuoto, Jeremy Koff, Victor Pikov, and others. Now in its 25th year of publishing, Neurotech Reports is the longest-serving publishing and market-intelligence firm serving the neuromodulation market. The report includes up-to-date information obtained at the 2025 meeting of the North American Neuromodulation Society, the 2025 JP Morgan Healthcare Conference, and other recent events. Data for the report was obtained from dozens of confidential interviews with key executives in the industry as well as numerous implanters of neuromodulation devices. 'There are a number of market research reports that claim to offer insight on the neuromodulation industry. But neuromodulation industry professionals should ask if they've ever seen the authors of those reports at key conferences such as NANS, INS, LSI. Neurotech Reports editors have been covering these events for 25 years and know the key players inside and out,' said James Cavuoto, editor and publisher of Neurotech Reports. 'This report draws on our 25 years of reporting on the neuromodulation industry.' Image caption: Neurotech Reports recently released its latest forecast on the growth of the market for implanted pain neuromodulation systems, which include spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) systems. NEWS SOURCE: Neurotech Reports Keywords: Biotechnology, Neurotech Reports, Market for Implanted Pain Neuromodulation Systems, Neurotech Business Report, Medical technology, biotech, medical devices, neurology, pharmaceuticals, spinal cord stimulation, SAN FRANCISCO, Calif.
Associated Press
17-03-2025
- Business
- Associated Press
Biogen VP to Keynote 2025 Bioelectronic Medicine Forum in NYC
Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Eighth Annual Bioelectronic Medicine Forum will take place on April 10, 2025. The one-day event will be held at the New York Academy of Medicine in Manhattan. Lisa Shafer, a vice president at biotech firm Biogen, will keynote the conference. Shafer has held executive management positions at key pharmaceutical firms such as Teva as well as neurotech firms such as Medtronic. In her distinguished career, she has helped bridge the gap between device and drug therapies as a chief scientific officer and product development executive. She earned her Ph.D. in neuroscience and neuroimmunology from Loyola University. German firm Precisis, OSA startup LunOSA, European neuroprosthetics firm ReVision, and focused ultrasound firm Sanmai will present for the first time at the meeting. Also presenting will be executives from NeuroSigma, ANEUVO, and Synergia Medical. Venture capital professionals Jeff Chu from Features Capital, Mir Imran from InCube Ventures, and Jeffrey Scott Cohen from Ladenburg Thalmann & Co will participate in a session moderated by JoJo Platt devoted to investment in bioelectronic medicine. Contributing editor Victor Pikov will moderate a session with executives from three firms in the neuromodulation space for treating obstructive sleep apnea, including market leader Inspire Medical Systems, and challengers Nyxoah and LivaNova. There will also be several informative panel discussions on key topics such as investment, emerging technologies, and reimbursement. Neurotech Reports editors James Cavuoto, Jeremy Koff, and JoJo Platt will moderate sessions at the event. Also at the event, former Axonics CEO Ray Cohen will sit down for a fireside chat with Neurotech Reports Senior Consulting Editor Jeremy Koff for a discussion on the bowel and bladder neuromodulation market. Cirtec Medical is the Platinum Sponsor of the conference. MST is the Gold Sponsor. Osypka and Black Swan IP are Bronze Sponsors. 'Bioelectronic medicine merges some of the best attributes of biopharma and neurotech approaches to treating systemic disorders,' said James Cavuoto, editor and publisher at Neurotech Reports. 'This eighth-annual conference will be a key meeting place for entrepreneurs and executives helping to build this industry.' Image caption: Medtech and pharmaceutical industry executive Lisa Shafer, Ph.D., will keynote the 2025 Bioelectronic Medicine Forum in New York City on April 10. NEWS SOURCE: Neurotech Reports Keywords: Biotechnology, Neurotech Reports, Lisa Shafer, Biogen VP, Keynote, 2025 Bioelectronic Medicine Forum NYC, Cirtec Medical, James Cavuoto, NEW YORK, N.Y. Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P124781 APNF0325A
Associated Press
30-01-2025
- Business
- Associated Press
Neurotech Reports Announces First European Leaders Forum
SAN FRANCISCO, Calif., Jan. 30, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the longest-serving publishing and market intelligence firm covering the neuromodulation industry, announced the launch of its first European management and investment conference. The two-day event, called Neurotech Leaders Forum at imec, will take place on June 3-4, 2025 on the campus of imec in Leuven, Belgium. Imec, a world-leading research and innovation center in nanoelectronics and digital technologies, is deeply committed to advancing health innovations through the power of semiconductor technologies, making it the ideal host for the conference. Tim Denison, Ph.D. FREng, co-founder of Amber Therapeutics, will keynote the conference. Denison also holds a joint appointment in engineering science and clinical neurosciences at Oxford University, where he explores the fundamentals of physiologic closed-loop systems. Prior to that, he was a technical fellow at Medtronic plc and vice president of research & core technology for the Restorative Therapies Group, where he helped oversee the design of next generation neural interface and algorithm technologies for the treatment of chronic neurological disease. At the conference, Neurotech Reports editor James Cavuoto will offer an update on the state of the European neuromodulation industry. Neurotech Reports editors JoJo Platt, Jeremy Koff, and Victor Pikov will moderate sessions devoted to peripheral nerve stimulation, bioelectronic medicine applications, venture capital investment, and regulatory and reimbursement issues affecting neurotech startups and emerging firms. Imec executives Peter Peumans, Paru Deshpande, and Barun Dutta (who conceived of, and led the Neuropixels program at imec since its inception) will also offer updates on technology advances at the European research and innovation center. Executives from several emerging neurotechnology startups, including Italian firm WISE srl and German firm Precisis, will also present at the conference during multiple entrepreneur panels. In addition to imec, sponsors of the conference include Cirtec Medical, MST, Valtronic, and Osypka. Neurotech Reports will also produce the 8th Annual Bioelectronic Medicine Forum on April 10, 2025 in New York City, and the 25th Annual Neurotech Leaders Forum San Francisco, on November 5-6, 2025. Image caption: Tim Denison will keynote the first European Neurotech Leaders Forum on June 3-4, 2025 at imec in Leuven, Belgium. NEWS SOURCE: Neurotech Reports Keywords: Surgery and Neurotechnology, Neurotech Leaders Forum, neurotechnology, Denison, Cavuoto, imec, Healthcare, Medical Technology, Biotech, Rehabilitation Medicine, SAN FRANCISCO, Calif. Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P123695 AP-R15TBLLI
